
Opinion|Videos|February 26, 2024
NCCN Guidelines: Implementing New Therapy Options for Ovarian Cancer
Ronald D. Alvarez, MD, MBA, discusses challenges in implementing updated NCCN guidelines, such as coverage limitations imposed by payers.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
In CLL, New Therapies Offer Potential for Personalized Approaches
4
ICYMI: Highlights From CROI 2025
5











































